What the labels and trials show
Mounjaro® is a once-weekly tirzepatide injection approved in the US for type 2 diabetes [1]. Its main table lists reactions in at least 5% of people on the medicine and more often than on placebo, and headache is not among them; nor is it in the postmarketing list [1]. The Canadian monograph, whose table goes down to 1%, does not include it [4], and the European product information, which pools 14 phase 3 studies, has no headache entry [3].
The strongest controlled answer comes from a 2025 meta-analysis of 12 randomised trials in 10,615 people with type 2 diabetes [5]. Tirzepatide did not change the risk of headache (risk ratio 1.00, 95% CI 0.65 to 1.55), although it did raise the risk of dizziness. In other words, headaches occurred at similar rates whether people were on tirzepatide or on the comparison treatment.
| Source | Headache finding | What it can and cannot show |
|---|---|---|
| Mounjaro® US, EU and Canadian labels | Not listed as a reaction; listed as a sign of low blood sugar [1][2][3][4] | Labels list effects above set thresholds |
| Meta-analysis, 12 trials in type 2 diabetes, 2025 | Risk ratio 1.00 versus control groups [5] | Randomised data; general headache, not by type |
| EudraVigilance analysis, 2026 | 2.51% of tirzepatide reports mention headache [6] | Share of reports, not a rate in users |
| Case series and cohort studies | Fewer migraine days in 2 patients; fewer headaches in a condition with raised brain pressure [7][11] | Small or observational; confounded by weight loss |
Why reports exist despite the trial data
A 2026 analysis of the European pharmacovigilance database looked for effects reported with semaglutide, liraglutide and tirzepatide that are not in each product’s summary of characteristics [6]. Headache made up 2.51% of tirzepatide reports. Spontaneous reports measure what people notice and send in; they cannot show how often headaches happen in users or whether the medicine caused them.
A headache that starts in the week after an injection is easy to attribute to the medicine, even when the trigger is something that changed at the same time, such as eating less, drinking less or cutting back on coffee. That does not make the headache less real; it means the cause is worth finding.
Mounjaro®-related triggers to check
Low blood sugar, documented: Mounjaro® raises the risk of low blood sugar, including severe episodes, when combined with insulin or a sulfonylurea [1]. Headache is one of the listed warning signs, alongside sweating, shakiness, hunger and confusion [2][10]. In the US trial of Mounjaro® added to basal insulin, readings below 54 mg/dL occurred in 14% to 19% on the medicine against 13% on placebo [1].
Dehydration, documented: vomiting, diarrhea and reduced drinking can lead to fluid loss, which the labels link to kidney problems [1][2]. MedlinePlus lists headache among the signs of mild to moderate dehydration, together with thirst and dark urine [9].
Eating and caffeine changes, plausible: Mounjaro® decreases food intake [1], and many people eat and drink differently on it. MedlinePlus names caffeine withdrawal, lack of sleep and alcohol as migraine triggers [8]. No study has measured these triggers specifically in Mounjaro® users.
Timing: tirzepatide reaches its peak level 8 to 72 hours after an injection [1], so a headache in that window does not prove a link, but noting it helps.
Headache causes outside the medicine
Most headaches are tension headaches, linked to tight neck, shoulder and scalp muscles and to stress, according to MedlinePlus [8]. Migraines, cluster headaches, sinus headaches and headaches from colds, flu or fever are also common [8]. Rebound headaches can follow regular use of pain relievers on three or more days a week [8].
Rarely, a headache points to something serious, such as bleeding around the brain, very high blood pressure, infection, raised pressure inside the skull or a stroke [8]. Sleep apnea can also cause headaches [8], which is relevant because many people with type 2 diabetes and obesity have it.
What helps
MedlinePlus suggests drinking water to avoid dehydration, especially after vomiting, resting in a quiet dark room, a cool cloth on the head and relaxation techniques [8]. For tension headaches it mentions over-the-counter pain relievers such as acetaminophen, aspirin or ibuprofen; ask your pharmacist which suits your kidneys and other medicines, and talk to your clinician if you need them three or more days a week [8].
A headache diary is MedlinePlus’s main tool for finding triggers: note the time, what you ate and drank in the previous 24 hours, how you slept and how long the pain lasted [8]. With Mounjaro®, adding your injection day and any glucose readings makes the diary more useful.
Research is also looking in the opposite direction: a two-patient case series reported fewer migraine days after starting tirzepatide, and a health-record study in idiopathic intracranial hypertension found fewer headaches in people given tirzepatide [7][11]. Both are preliminary, and the authors note weight loss as a confounder. They are not a reason to start, stop or change Mounjaro®.
Mounjaro® is a registered trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| A sudden, explosive headache, or the worst headache you have ever had | Emergency services | Emergency | MedlinePlus [8] |
| Headache with slurred speech, vision change, weakness in an arm or leg, loss of balance or confusion | Emergency services | Emergency | MedlinePlus [8] |
| Headache with fever, stiff neck, nausea and vomiting | Medical help right away | Today | MedlinePlus [8] |
| Headache with sweating, shakiness or hunger while on insulin or a sulfonylurea | Check and treat a low, then tell your prescriber | Today | Medication Guide [2]; MedlinePlus [10] |
| Headache with thirst and dark urine after vomiting or diarrhea that will not stop | Your prescriber | Today | Medication Guide [2]; MedlinePlus [9] |
| New headaches after age 50, or needing pain relievers on three or more days a week | Your clinician | At your next appointment | MedlinePlus [8] |
